抗体类配体

选项
视图 列表 网格

显示第1324个,产品总数820

设置降序方向
  1. Cetuximab (anti-EGFR)
      应用:
    • Animal Model
    • ELISA
    • Flow Cytometry
    • Functional Assay
    关联靶标: EGFR
    • 简短描述: Purity≥95% (SDS-PAGE&SEC-HPLC); Endotoxin Level< 0.01EU/μg; Human IgG1; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; Unconjugated
    • 种属反应性: 人(Human), 小鼠(Mouse), 食蟹猴(Cynomolgus monkey)
    • 亚型: Human IgG1
    • 宿主种属: 人(Human)
    • 偶联: Unconjugated
    CAS号: 205923-56-4
    分子式:        分子量: 145543.35
  2. Adalimumab (anti-TNF-alpha)
      应用:
    • Animal Model
    • ELISA
    • Flow Cytometry
    • Functional Assay
    关联靶标: ELANE PRTN3 TNF
    • 简短描述: 纯度>95%(SDS-PAGE&SEC);内毒素水平< 0.01EU/μg;人 IgG1;CHO;ELISA,FACS,功能检测,动物模型;非结合型
    • 种属反应性: 人(Human), 小鼠(Mouse), 恒河猴(Rhesus monkey), 食蟹猴(Cynomolgus monkey)
    • 亚型: Human IgG1
    • 宿主种属: 人(Human)
    • 偶联: Unconjugated
    CAS号: 331731-18-1
    IUPAC Name: 2-[[2-[[4-(2,2-dimethylpropanoyloxy)phenyl]sulfonylamino]benzoyl]amino]acetic acid
    SMILES: CC(C)(C)C(=O)OC1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC=C2C(=O)NCC(=O)O
    InChIKey: BTGNGJJLZOIYID-UHFFFAOYSA-N
    InChI: 1S/C20H22N2O7S/c1-20(2,3)19(26)29-13-8-10-14(11-9-13)30(27,28)22-16-7-5-4-6-15(16)18(25)21-12-17(23)24/h4-11,22H,12H2,1-3H3,(H,21,25)(H,23,24)
  3. Avelumab (anti-PD-L1)
      应用:
    • Animal Model
    • ELISA
    • Flow Cytometry
    • Functional Assay
    关联靶标: CD274
    • 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
    • 种属反应性: 人(Human), 兔(Rabbit), 大鼠(Rat), 小鼠(Mouse), 狗(Dog), 食蟹猴(Cynomolgus monkey)
    • 亚型: Human IgG1
    • 宿主种属: 人(Human)
    • 偶联: Unconjugated
    CAS号: 1537032-82-8        Compound CID : 168266339
    IUPAC Name: 4-O-[2-(tert-butylsulfonylamino)-2-phenylethyl] 1-O-methyl but-2-enedioate;4-O-[2-(cyclohexylmethylsulfonylamino)-2-phenylethyl] 1-O-methyl but-2-enedioate;4-O-[2-(cyclohexylsulfonylamino)-2-phenylethSee more
    SMILES: CCS(=O)(=O)NC(COC(=O)C=CC(=O)OC)C1=CC=CC=C1.CC(C)CS(=O)(=O)NC(COC(=O)C=CC(=O)OC)C1=CC=CC=C1.CC(C)S(=O)(=O)NC(COC(=O)C=CC(=O)OC)C1=CC=CC=C1.CC(C)(C)CS(=O)(=O)NC(COC(=O)C=CC(=O)OC)C1=CC=CC=C1.CC(C)(C)S(See more
    InChIKey: YRKYEQYAGDIKGE-UHFFFAOYSA-N
    InChI: 1S/C20H27NO6S.C19H25NO6S.C18H25NO6S.2C17H23NO6S.C16H21NO6S.C15H19NO6S.C14H17NO6S/c1-26-19(22)12-13-20(23)27-14-18(17-10-6-3-7-11-17)21-28(24,25)15-16-8-4-2-5-9-16;1-25-18(21)12-13-19(22)26-14-17(15-8-See more
  4. Tocilizumab (anti-IL-6R)
      应用:
    • Animal Model
    • ELISA
    • Flow Cytometry
    • Functional Assay
    关联靶标: IL6R IL6ST
    • 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
    • 种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey)
    • 亚型: Human IgG1
    • 宿主种属: 人(Human)
    • 偶联: Unconjugated
    CAS号: 375823-41-9
    IUPAC Name: 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol
    SMILES: C1=CC(=CC=C1C=CC2=CC(=CC(=C2)O)O)O
    InChIKey: LUKBXSAWLPMMSZ-OWOJBTEDSA-N
    InChI: 1S/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1+
每页